JABIL INC
JBLNYSE🏆 #400 by market capEarnings Dec 15US Equity
$290.93▲ $7.65 (+2.70%)
🌙 After hours$285.89▼ 1.73%Regular close · extended-hours price shownTrack JBL
Get earnings, price moves & breaking news on Telegram
24h▲ 2.7%
7d▲ 8.8%
14d▲ 1.3%
30d▼ 8.8%
ytd▲ 27.7%
1y▲ 30.8%
🏦Market Cap
$29.96B
Mid Cap
📈Revenue Growth (YoY)
20.6%
Healthy
📊Gross Margin
9.2%
Thin
💵FCF Margin
3.8%
Moderate
⚖️P/S Ratio
0.8x
Cheap
Otter Score
64
Fair
JABIL INC
JBLAnalyst Ratings
Price
$290.93
Total
23
Raised
3
Lowered
5
Avg PT
$434.75
H / L
$475 / $375
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
JP Morgan | Reiterated | Overweight | 2026-10-01 | — | — |
Argus Research | Reiterated | Buy | 2026-10-01 | $475.00 | +63.30% |
Barclays | Reiterated | Overweight | 2026-10-01 | $378.00 | +29.90% |
Goldman Sachs | Reiterated | Buy | 2026-09-08 | $375.00 | +28.90% |
UBS | Upgraded | Neutral → Buy | 2026-08-11 | $430.00 | +47.80% |
Stifel | Reiterated | Buy | 2026-06-18 | — | — |
Raymond James | Reiterated | Strong Buy | 2026-06-18 | $450.00 | +54.70% |
Baird | Reiterated | Outperform | 2026-06-18 | — | — |
B of A Securities | Reiterated | Buy | 2026-04-20 | — | — |
Credit Suisse | Reiterated | Outperform | 2023-06-16 | — | — |
Citigroup | Reiterated | Buy | 2022-06-17 | $90.00 | −69.10% |
RBC Capital | Reiterated | Sector Perform | 2020-09-25 | — | — |
Standpoint Research | Downgraded | Buy → Hold | 2019-11-01 | — | — |
Stifel Nicolaus | Reiterated | Hold | 2019-09-25 | $460.00 | +58.10% |
B. Riley FBR | Reiterated | Buy | 2018-05-05 | — | — |
Argus | Downgraded | Buy → Hold | 2018-05-05 | — | — |
B. Riley Securities | Downgraded | Buy → Neutral | 2016-12-07 | — | — |
Needham | Downgraded | Buy → Hold | 2016-09-23 | $470.00 | +61.60% |
Deutsche Bank | Reiterated | Hold | 2016-09-22 | — | — |
Cross Research | Upgraded | Hold → Buy | 2015-03-16 | — | — |
Scotiabank | Upgraded | Perform → Outperform | 2014-07-22 | — | — |
Longbow Research | Downgraded | Buy → Neutral | 2013-12-18 | — | — |
Bank of America | Reiterated | Buy | 2013-03-18 | — | — |
Institution
JP Morgan
Reiterated · Overweight · 2026-10-01
—
—
Argus Research
Reiterated · Buy · 2026-10-01
$475.00
+63.30%
Barclays
Reiterated · Overweight · 2026-10-01
$378.00
+29.90%
Goldman Sachs
Reiterated · Buy · 2026-09-08
$375.00
+28.90%
UBS
Upgraded · Neutral → Buy · 2026-08-11
$430.00
+47.80%
Stifel
Reiterated · Buy · 2026-06-18
—
—
Raymond James
Reiterated · Strong Buy · 2026-06-18
$450.00
+54.70%
Baird
Reiterated · Outperform · 2026-06-18
—
—
B of A Securities
Reiterated · Buy · 2026-04-20
—
—
Credit Suisse
Reiterated · Outperform · 2023-06-16
—
—
Citigroup
Reiterated · Buy · 2022-06-17
$90.00
−69.10%
RBC Capital
Reiterated · Sector Perform · 2020-09-25
—
—
Standpoint Research
Downgraded · Buy → Hold · 2019-11-01
—
—
Stifel Nicolaus
Reiterated · Hold · 2019-09-25
$460.00
+58.10%
B. Riley FBR
Reiterated · Buy · 2018-05-05
—
—
Argus
Downgraded · Buy → Hold · 2018-05-05
—
—
B. Riley Securities
Downgraded · Buy → Neutral · 2016-12-07
—
—
Needham
Downgraded · Buy → Hold · 2016-09-23
$470.00
+61.60%
Deutsche Bank
Reiterated · Hold · 2016-09-22
—
—
Cross Research
Upgraded · Hold → Buy · 2015-03-16
—
—
Scotiabank
Upgraded · Perform → Outperform · 2014-07-22
—
—
Longbow Research
Downgraded · Buy → Neutral · 2013-12-18
—
—
Bank of America
Reiterated · Buy · 2013-03-18
—
—
One row per institution · price target from the firm's latest published target